Generate a tailored SOP for Dr. Yung Chi Cheng. Improve your application with a focused, well-structured draft.
Yung-Chi Cheng is a noted researcher at Yale School of Medicine, focusing on the development of novel anti-cancer and anti-viral drugs. His work encompasses a wide range of cancers, including hepatocellular carcinoma, pancreatic cancer, colorectal cancer, rectal cancer, lung cancer, and melanoma. Additionally, he conducts extensive research in anti-viral treatments targeting hepatitis B, hepatitis C, human immunodeficiency virus, Epstein Barr Virus, and cytomegalovirus. Cheng's laboratory employs innovative systems biology approaches aimed at creating multi-targeted therapies for cancer and age-related diseases. Through his role in the Consortium for Globalization of Chinese Medicine, he collaborates with multiple prestigious institutions in China to advance the field of Chinese medicine.
Yale School of Medicine • New Haven, CT
Leading research in pharmacology and developing new therapeutic strategies.
Administered via the Graduate School of Arts and Sciences (GSAS). GRE General is optional for PhD.